Ji Li | Medicine and Health Sciences | Best Scholar Award

Published on by Forensic Scientist

Prof. Ji Li | Medicine and Health Sciences | Best Scholar Award

Central South University | China

Professor Ji Li, PhD, is a distinguished scholar in dermatological sciences, currently serving in the Department of Dermatology at Xiangya Hospital, Central South University, China. Renowned for groundbreaking research in inflammatory dermatosis and skin aging, Professor Ji has significantly advanced clinical and molecular dermatology through over a decade of academic contributions.

Author Profile👤

Scopus

Strengths for the Awards✨

Professor Ji Li, PhD, has firmly established herself as a leading figure in dermatological research, particularly in the areas of inflammatory dermatosis and skin aging. Her academic contributions are highly impactful, with over 100 SCI-indexed publications in prestigious international journals, such as BMJ, Science Advances, Developmental Cell, EMBO Journal, JAAD, JAMA Dermatology, and Journal of Investigative Dermatology. This extensive publication record underscores her sustained productivity and global recognition.

In addition to scholarly output, her ability to attract six projects funded by the National Natural Science Foundation of China (NSFC) demonstrates her competence in leading significant, peer-reviewed scientific research with national and institutional importance. Her dual roles as first and corresponding author reflect intellectual leadership and mentorship capability, making her a strong candidate for the Best Scholar Award.

🎓 Education

Professor Ji Li earned a Ph.D. in Dermatology and has since cultivated a strong academic foundation that supports both clinical excellence and scientific innovation. Their academic journey is rooted in top-tier institutions, combining rigorous research training with a focus on translational skin biology.

🧪 Experience

With a long-standing tenure at Xiangya Hospital, Professor Ji Li has blended clinical dermatology practice with laboratory-based investigation, leading several research groups and mentoring young scientists. With active involvement in national and international dermatological communities, Ji Li is recognized as a clinical-scientific leader in the field.

🔬 Research Interest On Medicine and Health Sciences

Professor Ji’s core research areas include:

  • Inflammatory dermatoses, exploring molecular mechanisms and treatment strategies

  • Skin aging, investigating cellular aging pathways and potential rejuvenation therapies
    These interests are supported by a rich body of work that bridges clinical needs and molecular science.

🏆 Award

Professor Ji Li has been honored with several prestigious recognitions, including grants from the National Natural Science Foundation of China (with 6 funded projects), underlining the scientific community’s acknowledgment of Ji’s excellence and innovation. The consistent impact of Ji’s work positions them as a leading nominee for the Best Scholar Award.

📚 Publications

Professor Ji Li has authored over 100 SCI-indexed papers as first or corresponding author, published in top-tier international journals. Notable recent publications include:

💡 Conclusion

Professor Ji Li exemplifies the values of the Best Scholar Award through a rare combination of clinical expertise, scientific vision, and impactful scholarship. With extensive contributions to inflammatory skin diseases and aging, an outstanding publication record, and robust grant support, Ji stands out as a trailblazer in dermatology research. Their leadership continues to inspire innovation, mentorship, and global collaboration.

Marwa Refaie | Medicine and Health Sciences | Pioneer Researcher Award

Published on by Forensic Scientist

Assist. Prof. Dr. Marwa Refaie | Medicine and Health Sciences | Pioneer Researcher Award

Minya University | Egypt

Dr. Marwa Monier Mahmoud Refaie is an esteemed Egyptian pharmacologist and academician currently serving as an Assistant Professor in the Department of Pharmacology, Faculty of Medicine, Minia University. With an H-index of 18 on both Scopus and Google Scholar, she has made impactful contributions to pharmacological research, particularly in drug safety, toxicology, and disease treatment models. Born on July 2, 1983, in Mallawi, El-Minia, Dr. Refaie balances her thriving career with family life, being a proud mother of three sons.

Professional profile👤

Google Scholar

Scopus

ORCID

Strengths for the Awards✨

Dr. Marwa Monier Mahmoud Refaie demonstrates a remarkable profile that aligns seamlessly with the ethos of the Pioneer Researcher Award. With over 16 years of academic and research experience in pharmacology, she has established herself as a thought leader in experimental and clinical pharmacology, especially in toxicology, nephroprotection, cardioprotection, and hormonal therapy research.

Her impressive H-index of 18 (Scopus & Google Scholar) reflects the consistent impact of her work on the scientific community. Dr. Refaie has authored over 40 international publications, many in high-impact journals, and has investigated novel therapeutic mechanisms for critical conditions like nephrotoxicity, PCOS, and ischemia-reperfusion injuries. Her robust experimental skill set, prolific mentorship of postgraduate students, and service on editorial boards of globally recognized journals (e.g., British Journal of Pharmacology, Elsevier journals) reflect both leadership and innovation in her field. Moreover, her multiple awards from Minia University for international publication over consecutive years affirm her consistency and excellence in pioneering pharmacological research.

🎓 Education

Dr. Refaie began her academic journey at Minia University, earning her MBBS in Medicine and Surgery in 2006. She further specialized in pharmacology, completing her Master’s in 2011 and a Ph.D. in Basic and Clinical Pharmacology in 2016. Expanding her interdisciplinary expertise, she also earned a Diploma in Infection Control in 2021, highlighting her dedication to integrated healthcare education and safety.

🧪 Experience

With over 16 years of academic and research experience, Dr. Refaie has evolved from a Demonstrator to Assistant Professor at Minia University. Her work spans teaching basic and clinical pharmacology to medical, dental, pharmacy, and nursing students, and supervising numerous M.Sc. and Ph.D. theses. Her research explores pharmacotherapy, cancer, autoimmune diseases, and drug safety, and she has actively contributed to institutional accreditation, infection control, and community healthcare education.

🔬 Research Interests On Medicine and Health Sciences

Dr. Refaie’s research is driven by a passion for understanding and combating toxicological and precancerous conditions. Her focus lies in modeling and treating organ-specific toxicity, ischemia-reperfusion injuries, and hyperplastic lesions. Her work also explores novel mechanisms of cardioprotection, reproductive toxicity, and immunomodulation using pharmacological agents such as diacerein, fenofibrate, and SGLT2 inhibitors.

🏆 Awards

Dr. Refaie has received consistent recognition for her excellence in research and publication. She was awarded first place at the 57th Annual Conference of the Egyptian Society of Pharmacology and Experimental Therapeutics (2018). Additionally, she has received Minia University’s International Publication Award for six consecutive years (2019–2024), reflecting her sustained contributions to global pharmacological science.

📚 Publications

  • Effect of coenzyme‐Q10 on doxorubicin‐induced nephrotoxicity in rats
    AAK El-Sheikh, MA Morsy, MM Mahmoud, RA Rifaai, AM Abdelrahman
    2012 – Cited by: 147

  • Possible protective effect of diacerein on doxorubicin‐induced nephrotoxicity in rats
    MMM Refaie, EF Amin, NF El-Tahawy, AM Abdelrahman
    2016 – Cited by: 96

  • Mechanism mediating the protective effect of diacerein in ischemia-reperfusion-induced testicular injury in rats
    SA Abdel-Gaber, RK Mohammed, MMM Refaie
    2018 – Cited by: 62

  • Protective mechanisms of coenzyme-Q10 may involve up-regulation of testicular P-glycoprotein in doxorubicin-induced toxicity
    AAK El-Sheikh, MA Morsy, MM Mahmoud, RA Rifaai
    2014 – Cited by: 52

  • Naringenin palliates cisplatin and doxorubicin gonadal toxicity in male rats
    AA Fouad, MMM Refaie, MI Abdelghany
    2019 – Cited by: 50

  • The role of interleukin‐1β and its antagonist (diacerein) in estradiol benzoate‐induced endometrial hyperplasia and atypia in female rats
    MMM Refaie, M El‐Hussieny
    2017 – Cited by: 48

  • Role of ATP-Sensitive Potassium Channel (KATP) and eNOS in Mediating the Protective Effect of Nicorandil in Cyclophosphamide-Induced Cardiotoxicity
    MMM Refaie, S Shehata, M El-Hussieny, WM Abdelraheem, …
    2020 – Cited by: 46

  • Assessment of Antibacterial and Anti-biofilm Effects of Vitamin C Against Pseudomonas aeruginosa Clinical Isolates
    WM Abdelraheem, MMM Refaie, RKM Yousef, AS Abd El Fatah, …
    2022 – Cited by: 44

  • Protective role of nebivolol in cadmium-induced hepatotoxicity via downregulation of oxidative stress, apoptosis and inflammatory pathways
    MMM Refaie, M El-Hussieny, NM Zenhom
    2018 – Cited by: 43

  • Protective effect of pioglitazone on ovarian ischemia reperfusion injury of female rats via modulation of peroxisome proliferator activated receptor gamma and heme-oxygenase 1
    MMM Refaie, M El-Hussieny
    2018 – Cited by: 41

📝 Conclusion

🌟 Dr. Marwa M. Refaie exemplifies excellence in academic pharmacology through her sustained research, impactful publications, and commitment to medical education. Her work spans cutting-edge experimental pharmacology, disease modeling, and immunotherapy. Her consistent accolades, active international collaborations, and editorial contributions to top journals affirm her candidacy as a distinguished nominee for prestigious research awards. Her legacy in pharmacological sciences continues to inspire and uplift the global scientific community.